跳至主要内容
临床试验/NCT04108169
NCT04108169Unknown不适用

A Chinese Registry to Evaluate the Association of Surgical Left Atrial Appendage Occlusion vs No Receipt of S-LAAO With Adverse Cardiovascular Events Among Petients Undergoing Coronary Artery Bypass Grafting.

Beijing Institute of Heart, Lung and Blood Vessel Diseases2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
240
试验地点
2
主要终点
All-cause death

研究概览

简要总结

This is a prospective, single-center, randomized, active controlled, clinical trail to assess the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients undergoing coronary artery bypass graft.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject undergoing coronary artery bypass grafting according to clinical indications;
  • Age is more than 18 and less than 80 years old;
  • Male and non pregnancy female;
  • Subject understands study requirements and agrees to sign an informed consent from prior to study procedures.

排除标准

  • Pregnancy female;
  • Participate in other clinical trial in the last 1 month.
  • Subject doesn't agree to sign an informed consent from prior to study procedures.
  • Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.
  • New York Heart Association (NYHA) Class IV heart failure.

结局指标

主要结局

All-cause death

时间窗: 3 year after discharge (These data is collected during follow-up visit at in-hospital)

次要结局

  • Atrial fibrillation(3 year after discharge (These data is collected during follow-up visit at in-hospital))
  • Composite of ischemic stroke, thromboembolism and all death(3 year after discharge (These data is collected during follow-up visit at in-hospital))

研究者

发起方
Beijing Institute of Heart, Lung and Blood Vessel Diseases
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验